DEAD

Serial Number

98066290

Owner

ABBVIE INC.

Attorney

Cheryl A. Withycombe

First Use Date

Jan 31, 2023

Filing Date

Jun 30, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ADMIRE Trademark

Serial Number: 98066290

ADMIRE is a trademark filed by ABBVIE INC. on June 30, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

ABBVIE INC. (311 trademarks)

1 N. WAUKEGAN ROAD
NORTH CHICAGO, IL 60064

Entity Type: 03

Legal Representation

Attorney of Record

Cheryl A. Withycombe

752 trademarks filed View all →

Correspondence Address

Cheryl A. Withycombe ABBVIE INC.

18655 TELLER AVENUE

MAIL CODE: AND-250C

IRVINE, CA 92612

United States

Trademark Details

Filing Date

June 30, 2023

Registration Date

Not Registered

First Use Anywhere

January 31, 2023

First Use in Commerce

January 31, 2023

Published for Opposition

November 14, 2023

Goods & Services

providing information about medical clinical trials, namely, information in the field of improving diversity and inclusion in clinical research studies and clinical trials.

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Aug 8, 2025 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Aug 8, 2025 ABN2

NOTIFICATION OF FINAL REFUSAL EMAILED

Apr 22, 2025 GNFN

FINAL REFUSAL E-MAILED

Apr 22, 2025 GNFR

SU - FINAL REFUSAL - WRITTEN

Apr 22, 2025 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 4, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 4, 2025 CRFA

ASSIGNED TO LIE

Apr 4, 2025 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 19, 2025 TROA

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Dec 18, 2024 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Dec 18, 2024 XELR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 19, 2024 GNRN

NON-FINAL ACTION E-MAILED

Sep 19, 2024 GNRT

SU - NON-FINAL ACTION - WRITTEN

Sep 19, 2024 CNRT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 16, 2024 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Sep 16, 2024 SUPC

SOU EXTENSION 1 GRANTED

Sep 16, 2024 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 16, 2024 AITU

USE AMENDMENT FILED

Jul 14, 2024 IUAF

SOU EXTENSION 1 FILED

Jul 14, 2024 EXT1

TEAS STATEMENT OF USE RECEIVED

Jul 14, 2024 EISU

SOU EXTENSION RECEIVED WITH TEAS PETITION

Jul 14, 2024 TPEX

NOTICE OF REVIVAL - E-MAILED

Jul 14, 2024 NREV

PETITION TO REVIVE-GRANTED

Jul 14, 2024 PETG

TEAS PETITION TO REVIVE RECEIVED

Jul 14, 2024 PROA

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 9, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 14, 2023 NPUB

PUBLISHED FOR OPPOSITION

Nov 14, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 25, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 9, 2023 CNSA

EXAMINER'S AMENDMENT ENTERED

Oct 9, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 9, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Oct 9, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Oct 9, 2023 CNEA

ASSIGNED TO EXAMINER

Oct 5, 2023 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Aug 2, 2023 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 1, 2023 NWOS

NEW APPLICATION ENTERED

Jul 4, 2023 NWAP

Related Trademarks

More from this Owner

ABBVIE MEDICAL INSTITUTE

TYLISCO

More in Same Class

NEXTDOT

UNGODLY

FROOOGS

DONORSYNC

EASYPARK

ANIMOTIVE